Cancer Studies: Drug Delivery and Chemistry

Cancer is one of the most serious fatal diseases in today’s world that kills millions of people every year. It is one of the major health concerns of the 21st century which does not have any boundary and can affect any organ of people from any place. Nanoparticles are rapidly being developed and trialed to overcome several limitations of traditional drug delivery systems and are coming up as a distinct therapeutics for cancer treatment. It is a challenge to eradicate tumor cells while sparing normal cells. We used magneto electric nanoparticles (mens) to control drug delivery and release.  Current treatment strategies for cancer also include combination of radiation, chemotherapy and surgery. Important issues in this research include physical-chemical assembly of the nanocarriers, their surface interactions with biological media, cellular interactions, and controlled content release from the carriers. Several strategies have been used to address mdr, especially p-glycoprotein-mediated drug resistance in tumors.

 

  • Magnetoelectric nanoparticles
  • Nanoparticle drug delivery
  • Problems of multidrug resistance in cancer therapies
  • Taxoids as potent cytotoxic agents for tumor targetting drug delivery

Related Conference of Cancer Studies: Drug Delivery and Chemistry

Cancer Studies: Drug Delivery and Chemistry Conference Speakers